Filtered By:
Drug: Nicotine
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 81 results found since Jan 2013.
E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020-2022
MMWR Morb Mortal Wkly Rep. 2023 Jun 23;72(25):672-677. doi: 10.15585/mmwr.mm7225a1.ABSTRACTE-cigarette products, related policies, and use patterns change rapidly. In the United States, the prevalence of e-cigarette use is markedly higher among youths and young adults than it is among adults overall. In 2021, 4.5% of all adults aged ≥18 years (an estimated 11.1 million) and 11.0% of young adults aged 18-24 years (an estimated 3.1 million) currently (≥1 day during the previous 30 days) used e-cigarettes; during 2022, 14.1% of high school students (an estimated 2.14 million) currently used e-cigarettes (1,2). E-cigarette...
Source: MMWR Morb Mortal Wkl... - June 22, 2023 Category: Epidemiology Authors: Fatma Romeh M Ali Andrew B Seidenberg Elisha Crane Elizabeth Seaman Michael A Tynan Kristy Marynak Source Type: research
Reactions to using other nicotine and tobacco products instead of menthol cigarettes: A qualitative study of people who smoke menthol cigarettes in the United States
Prev Med Rep. 2023 May 6;34:102228. doi: 10.1016/j.pmedr.2023.102228. eCollection 2023 Aug.ABSTRACTThe US Food and Drug Administration is considering banning menthol cigarettes, which could result in some people who smoke menthol cigarettes switching to other tobacco products (OTPs). This qualitative study explored reactions to using OTPs instead of menthol cigarettes. People who smoke menthol cigarettes (N=40) completed a behavioral economic assessment of the effects of menthol cigarette price increases on OTP purchasing. At the highest price, most participants could not afford menthol cigarettes. Instead, they could purc...
Source: Cancer Control - May 25, 2023 Category: Cancer & Oncology Authors: Rachel L Denlinger-Apte Ashley E Strahley Darcy E Lockhart Kimberly D Wiseman Rachel N Cassidy Danielle R Davis Richard J O'Connor Jennifer W Tidey Source Type: research
Lorcaserin: worthy of further insights? Results from recent research
CNS Neurol Disord Drug Targets. 2023 Mar 30. doi: 10.2174/1871527322666230330124137. Online ahead of print.ABSTRACTLorcaserin is a 3-benzazepine that binds 5-HT2C serotonin receptors in the hypothalamus, where it mediates lack of hunger and/or satiety, and in the ventral tegmental area, the site of origin of the mesolimbic and mesocortical dopaminergic projections, which mediate pleasure and reward. The drug has been first developed for the treatment of obesity, where it has shown efficacy, and subsequently trialed to counter substance use (mostly cocaine, cannabis, opioids, and nicotine) and craving, but showed inconsiste...
Source: CNS and Neurological Disorders Drug Targets - April 3, 2023 Category: Drugs & Pharmacology Authors: Marianna Mazza Georgios Demetrios Kotzalidis Giuseppe Marano Domenico De Berardis Giovanni Martinotti Enrico Romagnoli Giuseppe Biondi-Zoccai Antonio Abbate Gabriele Sani Source Type: research
Smoking Cessation Interventions
Am Fam Physician. 2022 Nov;106(5):513-522.ABSTRACTIn the United States, 1 in 5 adults uses tobacco products. Cigarette smoking is the leading cause of preventable disease and death in the United States despite its known health effects. Although nearly one-half of people who smoke try to quit each year, only up to 1 in 20 who quit without support achieve abstinence for at least six months. All patients, including school-aged children and adolescents, should be asked if they smoke and offered evidence-based treatments for smoking cessation. Use of the 5 A's framework (ask, advise, assess, assist, arrange) can help clinicians...
Source: American Family Physician - November 15, 2022 Category: Primary Care Authors: Heidi L Gaddey MaryAnn Dakkak Nicole Marie Jackson Source Type: research
Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes
Prev Med. 2022 Jul 20:107175. doi: 10.1016/j.ypmed.2022.107175. Online ahead of print.ABSTRACTThe United States Food and Drug Administration has the authority to reduce the nicotine content in cigarettes to minimal or non-addictive levels and could do so immediately or gradually over time. A large clinical trial compared the two approaches. This secondary analysis assesses abstinence and cessation-related outcomes one month after the trial concluded, when participants no longer had access to very low nicotine content (VLNC) research cigarettes. Smokers not interested in quitting (N = 1250) were recruited for the parent tri...
Source: Cancer Control - July 23, 2022 Category: Cancer & Oncology Authors: Elias M Klemperer Xianghua Luo Joni Jensen Mustafa Al'absi Paul M Cinciripini Jason D Robinson David J Drobes Joseph McClernon Andrew A Strasser Lori G Strayer Ryan Vandrey Neal L Benowitz Eric C Donny Dorothy K Hatsukami Source Type: research
Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021
MMWR Surveill Summ. 2022 Mar 11;71(5):1-29. doi: 10.15585/mmwr.ss7105a1.ABSTRACTPROBLEM/CONDITION: Commercial tobacco use is the leading cause of preventable disease, disability, and death in the United States. Most tobacco product use begins during adolescence. In recent years, tobacco products have evolved to include various combusted, smokeless, and electronic products.PERIOD COVERED: 2021.DESCRIPTION OF SYSTEM: The National Youth Tobacco Survey (NYTS) is an annual, cross-sectional, school-based, self-administered survey of U.S. middle school (grades 6-8) and high school (grades 9-12) students. A three-stage cluster sam...
Source: MMWR Surveill Summ - March 10, 2022 Category: Epidemiology Authors: Andrea S Gentzke Teresa W Wang Monica Cornelius Eunice Park-Lee Chunfeng Ren Michael D Sawdey Karen A Cullen Caitlin Loretan Ahmed Jamal David M Homa Source Type: research
